Authors: Bao, JL Sato, K Li, M Gao, YH Abid, R Aird, W Simons, M Post, MJ

Citation: Jl. Bao et al., PR-39 and PR-11 peptides inhibit ischemia-reperfusion injury by blocking proteasome-mediated I kappa B alpha degradation, AM J P-HEAR, 281(6), 2001, pp. H2612-H2618

Authors: Ulevitch, R Aird, W Taylor, F

Citation: R. Ulevitch et al., Question and answer session after scientific review, CRIT CARE M, 29(7), 2001, pp. S34-S35

Authors: Li, J Post, M Volk, R Gao, YH Li, M Metais, C Sato, K Tsai, J Aird, W Rosenberg, RD Hampton, TG Li, JY Sellke, F Carmeliet, P Simons, M

Citation: J. Li et al., PR39, a peptide regulator of angiogenesis (vol 6, pg 49, 2000), NAT MED, 6(3), 2000, pp. 356-356

Authors: Li, J Post, M Volk, R Gao, Y Li, M Metais, C Sato, K Tsai, J Aird, W Rosenberg, RD Hampton, TG Li, JY Sellke, F Carmeliet, P Simons, M

Citation: J. Li et al., PR39, a peptide regulator of angiogenesis, NAT MED, 6(1), 2000, pp. 49-55

Authors: Sternberg, DW Aird, W Neuberg, D Thompson, L MacNeill, K Amrein, P Shulman, LN

Citation: Dw. Sternberg et al., Treatment of patients with recurrent and primary refractory acute myelogenous leukemia using mitoxantrone and intermediate-dose cytarabine - A pharmacologically based regimen, CANCER, 88(9), 2000, pp. 2037-2041